Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592627 | SCV000706231 | benign | not specified | 2017-02-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001521986 | SCV001731433 | benign | Symmetrical dyschromatosis of extremities; Aicardi-Goutieres syndrome 6 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001548964 | SCV001768988 | benign | Aicardi-Goutieres syndrome 6 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001548965 | SCV001768989 | benign | Symmetrical dyschromatosis of extremities | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001521986 | SCV002809045 | benign | Symmetrical dyschromatosis of extremities; Aicardi-Goutieres syndrome 6 | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000592627 | SCV004101269 | benign | not specified | 2023-11-02 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied by a panel of primary immunodeficiencies. Number of patients: 96. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004714087 | SCV005279992 | benign | not provided | criteria provided, single submitter | not provided |